To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.

Medicare Coverage and Reimbursement issues, including the CMS Part B Drug Demonstration Proposed Rule; Medicare access to DXA services, including HR 2461, and legislative issues related to the CMS 2017 Hospital Outpatient Prospective Payment proposed rule; Medicare reimbursement for antimicrobial drugs, including related provisions in HR 512, The Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; and Medicare access to DXA services, including HR 2461, and legislative issues related to the CMS 2017 Hospital Outpatient Prospective Payment proposed rule. Legislative issues related to the FDA Regulation of Biosimilars. Legislative issues related to the CMS Part B Drug Demonstration Proposed Rule.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; Medicare access to DXA services, including HR 2461, and legislative issues related to the CMS 2017 Hospital Outpatient Prospective Payment proposed rule.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2461 the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2015.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2461 the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2015.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2461 the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2015.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2461, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2015.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2461, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2015.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2461, Increasing Access to Osteoporosis. Testing for Medicare Beneficiaries Act of 2015-meetings with staffers and developing of materials for advocacy purposes.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE